S&P 500   3,636.76 (+1.65%)
DOW   30,057.35 (+1.58%)
QQQ   294.39 (+1.38%)
AAPL   115.33 (+1.30%)
MSFT   212.85 (+1.30%)
FB   276.28 (+2.92%)
GOOGL   1,759.75 (+1.86%)
AMZN   3,119.21 (+0.67%)
TSLA   558.56 (+7.03%)
NVDA   520.10 (-1.05%)
BABA   278.46 (+3.09%)
CGC   26.83 (+8.54%)
GE   10.42 (+3.48%)
MU   63.47 (-1.11%)
AMD   85.21 (-0.12%)
T   29.22 (+2.10%)
NIO   53.93 (-2.62%)
F   9.41 (+6.21%)
ACB   9.04 (+25.91%)
NFLX   481.93 (+1.11%)
GILD   60.63 (+1.24%)
BA   219.41 (+3.73%)
DIS   151.15 (+3.54%)
S&P 500   3,636.76 (+1.65%)
DOW   30,057.35 (+1.58%)
QQQ   294.39 (+1.38%)
AAPL   115.33 (+1.30%)
MSFT   212.85 (+1.30%)
FB   276.28 (+2.92%)
GOOGL   1,759.75 (+1.86%)
AMZN   3,119.21 (+0.67%)
TSLA   558.56 (+7.03%)
NVDA   520.10 (-1.05%)
BABA   278.46 (+3.09%)
CGC   26.83 (+8.54%)
GE   10.42 (+3.48%)
MU   63.47 (-1.11%)
AMD   85.21 (-0.12%)
T   29.22 (+2.10%)
NIO   53.93 (-2.62%)
F   9.41 (+6.21%)
ACB   9.04 (+25.91%)
NFLX   481.93 (+1.11%)
GILD   60.63 (+1.24%)
BA   219.41 (+3.73%)
DIS   151.15 (+3.54%)
S&P 500   3,636.76 (+1.65%)
DOW   30,057.35 (+1.58%)
QQQ   294.39 (+1.38%)
AAPL   115.33 (+1.30%)
MSFT   212.85 (+1.30%)
FB   276.28 (+2.92%)
GOOGL   1,759.75 (+1.86%)
AMZN   3,119.21 (+0.67%)
TSLA   558.56 (+7.03%)
NVDA   520.10 (-1.05%)
BABA   278.46 (+3.09%)
CGC   26.83 (+8.54%)
GE   10.42 (+3.48%)
MU   63.47 (-1.11%)
AMD   85.21 (-0.12%)
T   29.22 (+2.10%)
NIO   53.93 (-2.62%)
F   9.41 (+6.21%)
ACB   9.04 (+25.91%)
NFLX   481.93 (+1.11%)
GILD   60.63 (+1.24%)
BA   219.41 (+3.73%)
DIS   151.15 (+3.54%)
S&P 500   3,636.76 (+1.65%)
DOW   30,057.35 (+1.58%)
QQQ   294.39 (+1.38%)
AAPL   115.33 (+1.30%)
MSFT   212.85 (+1.30%)
FB   276.28 (+2.92%)
GOOGL   1,759.75 (+1.86%)
AMZN   3,119.21 (+0.67%)
TSLA   558.56 (+7.03%)
NVDA   520.10 (-1.05%)
BABA   278.46 (+3.09%)
CGC   26.83 (+8.54%)
GE   10.42 (+3.48%)
MU   63.47 (-1.11%)
AMD   85.21 (-0.12%)
T   29.22 (+2.10%)
NIO   53.93 (-2.62%)
F   9.41 (+6.21%)
ACB   9.04 (+25.91%)
NFLX   481.93 (+1.11%)
GILD   60.63 (+1.24%)
BA   219.41 (+3.73%)
DIS   151.15 (+3.54%)
Log in
NYSE:PBH

Prestige Consumer Healthcare Price Target, Predictions & Analyst Ratings

$36.70
+0.84 (+2.34 %)
(As of 11/24/2020 03:12 PM ET)
Add
Compare
Today's Range
$36.39
Now: $36.70
$36.88
50-Day Range
$32.69
MA: $35.15
$37.55
52-Week Range
$27.40
Now: $36.70
$46.12
Volume11,274 shs
Average Volume453,648 shs
Market Capitalization$1.84 billion
P/E Ratio12.27
Dividend YieldN/A
Beta0.75

Analyst Ratings

Prestige Consumer Healthcare (NYSE:PBH) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
7 Wall Street analysts have issued ratings and price targets for Prestige Consumer Healthcare in the last 12 months. Their average twelve-month price target is $78.00, predicting that the stock has a possible upside of 112.53%. The high price target for PBH is $125.00 and the low price target for PBH is $39.00. There are currently 5 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
PBH Consensus Rating: HoldHoldHoldHold
PBH Consensus Rating Score: 2.292.142.142.14
PBH Analyst Ratings: 0 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
PBH Consensus Price Target: $78.00$69.00$69.00$71.00
PBH Price Target Upside: 112.53% upside82.03% upside82.03% upside84.83% upside

Prestige Consumer Healthcare (NYSE:PBH) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Prestige Consumer Healthcare (NYSE:PBH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/9/2020CIBCBoost Price TargetNeutral$100.00 ➝ $103.00Medium
11/6/2020TD SecuritiesBoost Price TargetBuy$115.00 ➝ $125.00High
11/6/2020BMO Capital MarketsBoost Price TargetMarket Perform$106.00 ➝ $112.00High
11/6/2020DA DavidsonLower Price TargetNeutral$45.00 ➝ $39.00High
6/29/2020SidotiUpgradeNeutral ➝ Buy$46.00High
6/17/2020OppenheimerReiterated RatingHoldLow
4/14/2020Jefferies Financial GroupDowngradeBuy ➝ HoldHigh
3/15/2019Royal Bank of CanadaReiterated RatingBuy$97.00Low
2/13/2019DesjardinsDowngradeHold$88.00Low
1/15/2019Raymond JamesDowngradeOutperform ➝ Market Perform$28.40Medium
2/5/2018KeyCorpLower Price TargetOverweight ➝ Overweight$54.00 ➝ $43.00Low
12/4/2017William BlairUpgradeMarket Perform ➝ OutperformHigh
(Data available from 11/24/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 11/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.